BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20833354)

  • 1. Colorectal cancer screening in an expanding panorama of screening programmes.
    Hoff G
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):521-7. PubMed ID: 20833354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for colorectal cancer.
    Hakama M; Hoff G; Kronborg O; Påhlman L
    Acta Oncol; 2005; 44(5):425-39. PubMed ID: 16118076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arguments against implementing a population-based screening programme for colorectal cancer].
    Bonneux L
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting US and European approaches to colorectal cancer screening: which is best?
    Hoff G; Dominitz JA
    Gut; 2010 Mar; 59(3):407-14. PubMed ID: 20207645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of primary care in colorectal cancer screening: experience from Czech Republic.
    Seifert B; Zavoral M; Fric P; Bencko V
    Neoplasma; 2008; 55(1):74-80. PubMed ID: 18190246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for colorectal cancer screening.
    Bretthauer M
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential impact of population-based colorectal cancer screening in Canada.
    Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E
    Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High participation rates are not necessary for cost-effective colorectal cancer screening.
    Howard K; Salkeld G; Irwig L; Adelstein BA
    J Med Screen; 2005; 12(2):96-102. PubMed ID: 15949121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screening.
    Berchi C; Guittet L; Bouvier V; Launoy G
    Int J Technol Assess Health Care; 2010 Jan; 26(1):48-53. PubMed ID: 20059780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based screening for colorectal cancer: Australian research and implementation.
    Young GP
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S33-42. PubMed ID: 19799696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Features of colorectal cancer with fecal-occult-blood tests--comparison with colorectal cancer with no screening].
    Takemasa I; Kikkawa N; Yasui M; Nishisho I; Fujitani K; Mishima H; Hasuike Y; Kobayashi K
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1514-8. PubMed ID: 9725042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The screening of sporadic colorectal cancer].
    Zavoral M
    Vnitr Lek; 2004 Oct; 50 Suppl 1():S103-6. PubMed ID: 15651152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of high-risk group with colorectal cancer].
    Xu AG; Yu ZJ; Zhong XH; Gan AH; Liu JH; Luo QY
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(2):116-8. PubMed ID: 20356496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.